Search results
Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Namita Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship.
1 day ago · Namita Thapar will offload 12,68,600 shares through the Emcure Pharma IPO and at the upper price band at Rs 1,008 per share, she will receive nearly Rs 128 crore. ... She has played an important role in the company’s growth and business expansion. Namita Thapar has invested in over 100 companies, including several startups that featured on Shark Tank India. In 2001, she earned an MBA from Duke University’s Fuqua School of Business. She is also a certified Chartered Accountant.
Namita Thapar is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies.
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies. She is also the founder of Thapar Entrepreneur Academy.
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals . She has also been a prominent investor in Shark Tank India investing in over 100 companies.
Namita Thapar will offload a partial stake of about 12.68 lakh shares under the OFS component. Net proceeds from the IPO will be utilised by the company for debt repayment and general corporate ...
Executive Director, India Business. Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, . Subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business.
4 days ago · Namita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on Shark Tank, is set to earn approximately Rs 127 crore through the company's upcoming IPO. The issue ...
3 days ago · Shark Tank fame Namita Thapar is expected to get 293 times return from her initial investment after partially offloading her stake in Emcure Pharma, as per the company's red herring prospectus. Thapar holds 63.39 lakh shares of Emcure Pharma, which represents a 3.5% stake in the company.
4 days ago · Emcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita Thapar, a Shark Tank India investor. Thapar to sell around 12.68 lakh shares through the offer for ...
